Evidence map›Paper›PMID 33330455›Full record

ArticleFrontiers in cell and developmental biology2020

Hypoxic Preconditioning Enhances Cellular Viability and Pro-angiogenic Paracrine Activity: The Roles of VEGF-A and SDF-1a in Rat Adipose Stem Cells.

Yang Zhao, Ming Zhang, Guo-Liang Lu, Bao-Xing Huang, Da-Wei Wang, Yuan Shao, Mu-Jun Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Stem Cell-Based Therapy for Diabetic Foot Ulcers.Frontiers in cell and developmental biology · 2022
    Review
  12. Review
  13. Recent Advances in Gene Therapy for Cardiac Tissue Regeneration.International journal of molecular sciences · 2021
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yang ZhaoDepartment of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Ming ZhangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Guo-Liang LuDepartment of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Bao-Xing HuangDepartment of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Da-Wei WangDepartment of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yuan ShaoDepartment of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Mu-Jun LuDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To achieve the full therapeutic potential of implanted adipose stem cells (ASCs)

Indexed as

adipose stem cellscellular viabilityhypoxic preconditioningpro-angiogenesistissue engineering

Identifiers

PMID33330455
PMCPMC7719676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.